Evidence map›Paper›PMID 40760187›Full record

ArticleSocial psychiatry and psychiatric epidemiology2026

Identifying the vulnerable among the vulnerable: applying quantitative intersectionality methods to assess potential inequities in the HIV continuum of care for people living with schizophrenia in the united States.

Paul Wesson, Eric Vittinghoff, Marilyn D Thomas, Stephen Crystal, Richard Hermida, James Walkup, Francine Cournos, Mark Olfson, Christina Mangurian

Abstract read
In one paragraph

Article in Social psychiatry and psychiatric epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Paul WessonDepartment of Epidemiology and Biostatistics, School of MedicineUniversity of California, San Francisco UCSF, 550 16th Street, 3rd Floor, Box 0886, 94143, San Francisco, CA, USA. paul.wesson@ucsf.edu.
Eric VittinghoffDepartment of Epidemiology and Biostatistics, School of MedicineUniversity of California, San Francisco UCSF, 550 16th Street, 3rd Floor, Box 0886, 94143, San Francisco, CA, USA.
Marilyn D ThomasDepartment of Epidemiology and Biostatistics, School of MedicineUniversity of California, San Francisco UCSF, 550 16th Street, 3rd Floor, Box 0886, 94143, San Francisco, CA, USA.
Stephen CrystalInstitute for Health, Health Care Policy, and Aging Research, Rutgers University, New Brunswick, NJ, USA.
Richard HermidaInstitute for Health, Health Care Policy, and Aging Research, Rutgers University, New Brunswick, NJ, USA.
James WalkupInstitute for Health, Health Care Policy, and Aging Research, Rutgers University, New Brunswick, NJ, USA.
Francine CournosDepartment of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
Mark OlfsonDepartment of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
Christina MangurianDepartment of Epidemiology and Biostatistics, School of MedicineUniversity of California, San Francisco UCSF, 550 16th Street, 3rd Floor, Box 0886, 94143, San Francisco, CA, USA.

Funding

Opioid Overdoses among Medicaid Beneficiaries: Predictors, Outcomes, and State Policy EffectsR01DA047347 · NIDA · RUTGERS, THE STATE UNIV OF N.J. · PI CRYSTAL, STEPHEN · 2019 to 2022
$3.1M
The science for the last mile: Enhanced epidemiologic surveillance to accelerate HIV eliminationK01AI145572 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WESSON, PAUL DOUGLAS · 2020 to 2024
$679k
National Science Foundation NSF 2305330NIAID NIH HHS K01 AI145572NIH HHS 1R01MH112420NIH HHS NIH/NIAID K01 AI145572NIH HHS R01 DA047347
6 · The paper itself

Abstract

backgroundPeople living with schizophrenia face disproportionate risk of HIV, yet HIV testing remains low. Differential testing rates and engagement in care may be impacted by compounding social marginalization, partly linked to structural barriers. Grounded in intersectionality, we set out to identify the riskiest intersectional positions for HIV testing and engagement in HIV care in the United States.

methodsWe created a retrospective cohort of people living with schizophrenia and matched controls, using 2012 national Medicaid claims data. We coded intersectional positions based on schizophrenia diagnosis, race/ethnicity, sex, and age. We used Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA) models to assess intersectional effects for two outcomes, HIV testing and retention in HIV care (RIC) defined as ≥2 CD4 or HIV viral load tests ≥90 days apart.

resultsOf 777,887 patients in the testing cohort, 7.7% tested for HIV; 39% of the 17,913 patients in the RIC cohort were retained in care. In MAIHDA models without fixed effects, intersectional positions explained 12.7% of the variance in HIV testing and 7.4% of the variance in RIC. In final models including fixed and random effects, intersectional positions accounted for 1.4% of the variance in HIV testing and 0.8% of the variance in RIC. Older Black men with schizophrenia had lower-than-expected RIC prevalence in final models.

conclusionIntersectional MAIHDA models can identify both vulnerable and resilient intersectional positions. The antagonistic intersectional effects for older Black men with schizophrenia highlight the need for targeted interventions to address structural barriers.

Indexed as

Continuity of Patient CareHealthcare DisparitiesHIV InfectionsSchizophreniaVulnerable PopulationsAdultFemaleHIV TestingHumansMaleMedicaidMiddle AgedRetrospective StudiesUnited StatesIntersectionalityMedicaidMulit-level modelingRetention in HIV careSchizophrenia, HIV testing

Identifiers

PMID40760187
PMCPMC13021718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.